#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Whole Genome Sequencing Identifies a 78 kb Insertion from Chromosome 8 as the Cause of Charcot-Marie-Tooth Neuropathy CMTX3


Next generation sequencing technologies have greatly advanced disease gene discovery for Charcot-Marie-Tooth (CMT) disease and related inherited peripheral neuropathies. However, many families with CMT remain unsolved after all protein-coding sequences have been interrogated through whole exome sequencing. The pathogenic mutations in these unsolved families may be non-coding point mutations, small indels or large structural variations involving thousands to millions of base pairs. In two large, distantly related families with X-linked CMT, all known protein-coding sequence variants were tested and no causal variant was found. Using whole genome sequencing we identified a 78 kb 8q24.3 insertion at chromosome Xq27.1 as the likely underlying cause of neuropathy in these two families. This is the first report of a large insertion causing CMT and highlights an understudied disease mechanism for inherited peripheral neuropathy.


Vyšlo v časopise: Whole Genome Sequencing Identifies a 78 kb Insertion from Chromosome 8 as the Cause of Charcot-Marie-Tooth Neuropathy CMTX3. PLoS Genet 12(7): e32767. doi:10.1371/journal.pgen.1006177
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1006177

Souhrn

Next generation sequencing technologies have greatly advanced disease gene discovery for Charcot-Marie-Tooth (CMT) disease and related inherited peripheral neuropathies. However, many families with CMT remain unsolved after all protein-coding sequences have been interrogated through whole exome sequencing. The pathogenic mutations in these unsolved families may be non-coding point mutations, small indels or large structural variations involving thousands to millions of base pairs. In two large, distantly related families with X-linked CMT, all known protein-coding sequence variants were tested and no causal variant was found. Using whole genome sequencing we identified a 78 kb 8q24.3 insertion at chromosome Xq27.1 as the likely underlying cause of neuropathy in these two families. This is the first report of a large insertion causing CMT and highlights an understudied disease mechanism for inherited peripheral neuropathy.


Zdroje

1. Saporta ASD, Sottile SL, Miller LJ, Feely SME, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol. 2011;69: 22–33. doi: 10.1002/ana.22166 21280073

2. Drew AP, Zhu D, Kidambi A, Ly C, Tey S, Brewer MH, et al. Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Mol Genet Genomic Med. 2015;3: 143–154. doi: 10.1002/mgg3.126 25802885

3. Choi B-O, Koo SK, Park M-H, Rhee H, Yang S-J, Choi K-G, et al. Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease. Hum Mutat. 2012;33: 1610–1615. doi: 10.1002/humu.22143 22730194

4. Schabhüttl M, Wieland T, Senderek J, Baets J, Timmerman V, De Jonghe P, et al. Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges. J Neurol. 2014;261: 970–982. doi: 10.1007/s00415-014-7289-8 24627108

5. Ionasescu VV, Trofatter J, Haines JL, Summers AM, Ionasescu R, Searby C. Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy. Am J Hum Genet. 1991;48: 1075–1083. 1674639

6. Huttner IG, Kennerson ML, Reddel SW, Radovanovic D, Nicholson GA. Proof of genetic heterogeneity in X-linked Charcot-Marie-Tooth disease. Neurology. 2006;67: 2016–2021. 17159110

7. Brewer MH, Changi F, Antonellis A, Fischbeck K, Polly P, Nicholson G, et al. Evidence of a founder haplotype refines the X-linked Charcot-Marie-Tooth (CMTX3) locus to a 2.5 Mb region. Neurogenetics. 2008;9: 191–195. doi: 10.1007/s10048-008-0126-4 18458969

8. Chaudhry R, Kidambi A, Brewer MH, Antonellis A, Mathews K, Nicholson G, et al. Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation. Muscle Nerve. 2013;47: 922–924. doi: 10.1002/mus.23743 23553728

9. Brewer MH. Molecular genetics of X-linked Charcot-Marie-Tooth neuropathy (CMTX3). Ph.D. Thesis, University of Sydney. 2011. Available: http://opac.library.usyd.edu.au:80/record=b3855774~S4.

10. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467: 1061–1073. doi: 10.1038/nature09534 20981092

11. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29: 308–311. 11125122

12. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord. 1991;1: 93–97. 1822787

13. Lupski JR, De Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991;66: 219–232. 1677316

14. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet. 1992;1: 176–179. 1303231

15. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992;1: 159–165. 1303228

16. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet. 1992;1: 171–175. 1303230

17. Valentijn LJ, Bolhuis PA, Zorn I, Hoogendijk JE, Van Den Bosch N, Hensels GW, et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet. 1992;1: 166–170. 1303229

18. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993;72: 143–151. 8422677

19. Huang J, Wu X, Montenegro G, Price J, Wang G, Vance JM, et al. Copy number variations are a rare cause of non-CMT1A Charcot-Marie-Tooth disease. J Neurol. 2010;257: 735–741. doi: 10.1007/s00415-009-5401-2 19949810

20. Høyer H, Braathen GJ, Eek AK, Nordang GBN, Skjelbred CF, Russell MB. Copy Number Variations in a Population-Based Study of Charcot-Marie-Tooth Disease. Biomed Res Int. 2015;2015: 1–7.

21. Pehlivan D, Beck CR, Okamoto Y, Harel T, Akdemir ZHC, Jhangiani SN, et al. The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy. Genet Med. 2015: 725–726.

22. Høyer H, Braathen GJ, Eek AK, Skjelbred CF, Russell MB. Charcot-Marie-Tooth caused by a copy number variation in myelin protein zero. Eur J Med Genet. 2011;54: e580–e583. doi: 10.1016/j.ejmg.2011.06.006 21787890

23. Maeda MH, Mitsui J, Soong B-W, Takahashi Y, Ishiura H, Hayashi S, et al. Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease. Ann Neurol. 2012;71: 84–92. doi: 10.1002/ana.22658 22275255

24. Ainsworth PJ, Bolton CF, Murphy BC, Stuart JA, Hahn AF. Genotype/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene. Hum Genet. 1998;103: 242–244. 9760211

25. Lin C, Numakura C, Ikegami T, Shizuka M, Shoji M, Nicholson G, et al. Deletion and nonsense mutations of the connexin 32 gene associated with Charcot-Marie-Tooth disease. Tohoku J Exp Med. 1999;188: 239–244. 10587015

26. Nakagawa M, Takashima H, Umehara F, Arimura K, Miyashita F, Takenouchi N, et al. Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci. 2001;185: 31–37. 11266688

27. Østern R, Fagerheim T, Hjellnes H, Nygård B, Mellgren SI, Nilssen Ø. Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies. BMC Med Genet. 2013;14: 94. doi: 10.1186/1471-2350-14-94 24053775

28. Okamoto Y, Goksungur MT, Pehlivan D, Beck CR, Gonzaga-Jauregui C, Muzny DM, et al. Exonic duplication CNV of NDRG1 associated with autosomal-recessive HMSN-Lom/CMT4D. Genet Med. 2013;16.

29. Lupiáñez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E, et al. Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell. 2015;161: 1012–1025. doi: 10.1016/j.cell.2015.04.004 25959774

30. Weterman MaJ, Van Ruissen F, De Wissel M, Bordewijk L, Samijn JPA, Van Der Pol WL, et al. Copy number variation upstream of PMP22 in Charcot-Marie-Tooth disease. Eur J Hum Genet. 2010;18: 421–428. doi: 10.1038/ejhg.2009.186 19888301

31. Zhang F, Seeman P, Liu P, Weterman MaJ, Gonzaga-Jauregui C, Towne CF, et al. Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability. Am J Hum Genet. 2010;86: 892–903. doi: 10.1016/j.ajhg.2010.05.001 20493460

32. Jones EA, Brewer MH, Srinivasan R, Krueger C, Sun G, Charney KN, et al. Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22. Hum Mol Genet. 2012;21: 1581–1591. doi: 10.1093/hmg/ddr595 22180461

33. Kleinjan DA, Van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet. 2005;76: 8–32. 15549674

34. Spielmann M, Mundlos S. Structural variations, the regulatory landscape of the genome and their alteration in human disease. Bioessays. 2013;35: 533–543. doi: 10.1002/bies.201200178 23625790

35. Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485: 376–380. doi: 10.1038/nature11082 22495300

36. Bowl MR, Nesbit MA, Harding B, Levy E, Jefferson A, Volpi E, et al. An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism. J Clin Invest. 2005;115: 2822–2831. 16167084

37. Zhu H, Shang D, Sun M, Choi S, Liu Q, Hao J, et al. X-linked congenital hypertrichosis syndrome is associated with interchromosomal insertions mediated by a human-specific palindrome near SOX3. Am J Hum Genet. 2011;88: 819–826. doi: 10.1016/j.ajhg.2011.05.004 21636067

38. Destefano GM, Fantauzzo KA, Petukhova L, Kurban M, Tadin-Strapps M, Levy B, et al. Position effect on FGF13 associated with X-linked congenital generalized hypertrichosis. Proc Natl Acad Sci U S A. 2013;110: 7790–7795. doi: 10.1073/pnas.1216412110 23603273

39. Bunyan DJ, Robinson DO, Tyers AG, Huang S, Maloney VK, Grand FH, et al. X-Linked Dominant Congenital Ptosis Cosegregating with an Interstitial Insertion of a Chromosome 1p21.3 Fragment into a Quasipalindromic Sequence in Xq27.1. Open Journal of Genetics. 2014;04: 415–425.

40. Haines B, Hughes J, Corbett M, Shaw M, Innes J, Patel L, et al. Interchromosomal insertional translocation at Xq26.3 alters SOX3 expression in an individual with XX male sex reversal. J Clin Endocrinol Metab. 2015;100: jc.2014-4383.

41. Cotton AM, Avila L, Penaherrera MS, Affleck JG, Robinson WP, Brown CJ. Inactive X chromosome-specific reduction in placental DNA methylation. Hum Mol Genet. 2009;18: 3544–3552. doi: 10.1093/hmg/ddp299 19586922

42. Smallwood PM, Munoz-Sanjuan I, Tong P, Macke JP, Hendry SH, Gilbert DJ, et al. Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci U S A. 1996;93: 9850–9857. 8790420

43. Weckselblatt B, Rudd MK. Human Structural Variation: Mechanisms of Chromosome Rearrangements. Trends Genet. 2015;31: 587–599. doi: 10.1016/j.tig.2015.05.010 26209074

44. Carvalho CMB, Lupski JR. Mechanisms underlying structural variant formation in genomic disorders. Nature reviews Genetics. 2016;17: 224–238. doi: 10.1038/nrg.2015.25 26924765

45. Hastings PJ, Ira G, Lupski JR. A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet. 2009;5: e1000327. doi: 10.1371/journal.pgen.1000327 19180184

46. Onozawa M, Zhang Z, Kim YJ, Goldberg L, Varga T, Bergsagel PL, et al. Repair of DNA double-strand breaks by templated nucleotide sequence insertions derived from distant regions of the genome. Proc Natl Acad Sci U S A. 2014;111: 7729–7734. doi: 10.1073/pnas.1321889111 24821809

47. Kurahashi H, Inagaki H, Ohye T, Kogo H, Kato T, Emanuel BS. Palindrome-mediated chromosomal translocations in humans. DNA repair. 2006;5: 1136–1145. 16829213

48. Zhang F, Khajavi M, Connolly AM, Towne CF, Batish SD, Lupski JR. The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet. 2009;41: 849–853. doi: 10.1038/ng.399 19543269

49. Sakofsky CJ, Ayyar S, Deem AK, Chung WH, Ira G, Malkova A. Translesion Polymerases Drive Microhomology-Mediated Break-Induced Replication Leading to Complex Chromosomal Rearrangements. Mol Cell. 2015;60: 860–872. doi: 10.1016/j.molcel.2015.10.041 26669261

50. Belkadi A, Bolze A, Itan Y, Cobat A, Vincent QB, Antipenko A, et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proc Natl Acad Sci U S A. 2015: 1418631112-.

51. Zhang Y, Haraksingh R, Grubert F, Abyzov A, Gerstein M, Weissman S, et al. Child Development and Structural Variation in the Human Genome. Child Dev. 2013;84: 34–48. doi: 10.1111/cdev.12051 23311762

52. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature. 2006;444: 444–454. 17122850

53. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet. 2006;7: 85–97. 16418744

54. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England). 2009;25: 1754–1760.

55. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25: 402–408. 11846609

Štítky
Genetika Reprodukčná medicína
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#